Go Therapeutics
GO Therapeutics is exploiting unique aspects of cancer cell biology to develop a new class of cancer therapies for previously intractable solid tumors. We target O-linked glycoproteins specific to cancer cells to develop proprietary, high-affinity antibodies to novel cancer-specific targets. Our antibodies are the basis for a broad array of potent cancer-killing modalities including T-cell bispecifics (TCBs), CAR-T, and antibody drug conjugates (ADCs). Each are designed to kill cancer while sparing healthy tissue.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
9
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
40
organic / mo
Sign up free to see all 2 verified contacts at Go Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
- AG
Aaron Groen
Senior Director · Research & Development
EmailPhone - NS
Nisha Shrestha
Senior Scientist · Research & Development
EmailPhone
Showing 2 of 2 verified contacts
Top roles at Go Therapeutics
2 distinct titles indexed · top 2 shown.
- 1senior director
- 1senior scientist
Sign up to unlock all 2 contacts at Go Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Go Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.